Protective effect of adenosine receptors against lipopolysaccharide-induced acute lung injury

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 306, Issue 6, 2014, Pages

  Gonzales, Joyce N ^a   Gorshkov, Boris ^a   Varn, Matthew N ^a   Zemskova, Marina A ^a   Zemskov, Evgeny A ^a   Sridhar, Supriya ^a   Lucas, Rudolf ^a   Verin, Alexander D ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

Acute lung injury; Adenosine; Lipopolysaccharide; Pulmonary edema; Receptors

Indexed keywords

ADENOSINE; ADENOSINE 5' (N ETHYLCARBOXAMIDE); ADENOSINE A2A RECEPTOR; ADENOSINE A3 RECEPTOR; ADENOSINE RECEPTOR; ALBUMIN; CYTOKINE; EVANS BLUE; LIPOPOLYSACCHARIDE; MYELOPEROXIDASE; ADENOSINE RECEPTOR STIMULATING AGENT; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ACUTE LUNG INJURY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL PERMEABILITY; CONTROLLED STUDY; DRUG EFFECT; ENDOTHELIUM CELL; EXTRAVASATION; HISTOLOGY; INFLAMMATION; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; RECEPTOR UPREGULATION; RESPIRATORY DISTRESS; SIGNAL TRANSDUCTION; ADULT RESPIRATORY DISTRESS SYNDROME; ANIMAL; C57BL MOUSE; CAPILLARY PERMEABILITY; CELL COUNT; CHEMICALLY INDUCED DISORDER; CYTOLOGY; ENDOTHELIUM; LUNG; LUNG EDEMA; LUNG LAVAGE; METABOLISM; PHYSIOLOGY; RECEPTORS;

ACUTE LUNG INJURY; ADENOSINE; LIPOPOLYSACCHARIDE; PULMONARY EDEMA; RECEPTORS;

ACUTE LUNG INJURY; ADENOSINE; ADENOSINE-5'-(N-ETHYLCARBOXAMIDE); ANIMALS; BRONCHOALVEOLAR LAVAGE FLUID; CAPILLARY PERMEABILITY; CELL COUNT; CYTOKINES; ENDOTHELIAL CELLS; ENDOTHELIUM; INFLAMMATION; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; LUNG; MICE; MICE, INBRED C57BL; PURINERGIC P1 RECEPTOR AGONISTS; RECEPTORS, PURINERGIC P1; RESPIRATORY DISTRESS SYNDROME, ADULT; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84900023299     PISSN: 10400605     EISSN: 15221504     Source Type: Journal    
DOI: 10.1152/ajplung.00086.2013     Document Type: Article

References (54)

1. Bastarache JA, Blackwell TS. Development of animal models for the acute respiratory distress syndrome. Dis Model Mech 2: 218-223, 2009.
2. Bersten A, Sibbald WJ. Acute lung injury in septic shock. Crit Care Clin 5: 49-79, 1989.
3. Burnstock G, Brouns I, Adriaensen D, Timmermans JP. Purinergic signaling in the airways. Pharmacol Rev 64: 834-868, 2012.
4. Csóka B, Németh ZH, Rosenberger P, Eltzschig HK, Spolarics Z, Pacher P, Selmeczy Z, Koscsó B, Himer L, Vizi ES, Blackburn MR, Deitch EA, Haskó G. A2B adenosine receptors protect against sepsisinduced mortality by dampening excessive inflammation. J Immunol 185: 542-550, 2010.
5. Dudek SM, Garcia JG. Cytoskeletal regulation of pulmonary vascular permeability. J Appl Physiol 91: 1487-1500, 2001.
6. Eckle T, Faigle M, Grenz A, Laucher S, Thompson LF, Eltzschig HK. A2B adenosine receptor dampens hypoxia-induced vascular leak. Blood 111: 2024-2035, 2008.
7. Eckle T, Grenz A, Laucher S, Eltzschig HK. A2B adenosine receptor signaling attenuates acute lung injury by enhancing alveolar fluid clearance in mice. J Clin Invest 118: 3301-3315, 2008.
8. Eckle T, Koeppen M, Eltzschig HK. Role of extracellular adenosine in acute lung injury. J Physiol 24: 298-306, 2009.
9. Ehrentraut H, Westrich JA, Eltzschig HK, Clambey ET. Adora2b adenosine receptor engagement enhances regulatory T cell abundance during endotoxin-induced pulmonary inflammation. PloS One 7: e32416, 2012.
10. Factor P, Mutlu GM, Chen L, Mohameed J, Akhmedov AT, Meng FJ, Jilling T, Lewis ER, Johnson MD, Xu A, Kass D, Martino JM, Bellmeyer A, Albazi JS, Emala C, Lee HT, Dobbs LG, Matalon S. Adenosine regulation of alveolar fluid clearance. Proc Natl Acad Sci USA 104: 4083-4088, 2007.
11. Folkesson HG, Kuzenko SR, Lipson DA, Matthay MA, Simmons MA. The adenosine 2A receptor agonist GW328267C improves lung function after acute lung injury in rats. Am J Physiol Lung Cell Mol Physiol 303: L259-L271, 2012.
12. Fortin A, Harbour D, Fernandes M, Borgeat P, Bourgoin S. Differential expression of adenosine receptors in human neutrophils: up-regulation by specific Th1 cytokines and lipopolysaccharide. J Leukoc Biol 79: 574-585, 2006.
13. Fredholm BB, Irenius E, Kull B, Schulte G. Comparison of the potency of adenosine as an agonist at human adenosine receptors expressed in Chinese hamster ovary cells. Biochem Pharmacol 61: 443-448, 2001.
14. Grinnell KL, Chichger H, Braza J, Duong H, Harrington EO. Protection against LPS-induced pulmonary edema through the attenuation of protein tyrosine phosphatase-1B oxidation. Am J Respir Cell Mol Biol 46: 623-632, 2012.
15. Grommes J, Soehnlein O. Contribution of neutrophils to acute lung injury. Mo Med 17: 293-307, 2011.
16. Haas B, Leonard F, Ernens I, Rodius S, Vausort M, Rolland-Turner M, Devaux Y, Wagner DR. Adenosine reduces cell surface expression of toll-like receptor 4 and inflammation in response to lipopolysaccharide and matrix products. J Cardiovasc Transl Res 4: 790-800, 2011.
17. Hardman JG, Limbird LE, Molinoff PB, Ruddon RW, Goodman Gilman A. Goodman & Gilman's The Pharmacological Basis of Therapeutics, 9th ed. New York: McGraw-Hill, Health Professions Division, 1996.
18. Harrington EO, Newton J, Morin N, Rounds S. Barrier dysfunction and RhoA activation are blunted by homocysteine and adenosine in pulmonary endothelium. Am J Physiol Lung Cell Mol Physiol 287: L1091-L1097, 2004.
19. Haskó G, Pacher P. A2A receptors in inflammation and injury: lessons learned from transgenic animals. J Leukoc Biol 83: 447-455, 2008.
20. Haskó G, Xu DZ, Lu Q, Németh ZH, Jabush J, Berezina TL, Zaets SB, Csóka B, Deitch EA. Adenosine A2A receptor activation reduces lung injury in trauma/hemorrhagic shock. Crit Care Med 34: 1119-1125, 2006.
21. Heller AR, Rothermel J, Weigand MA, Plaschke K, Schmeck J, Wendel M, Bardenheuer HJ, Koch T. Adenosine A1 and A2 receptor agonists reduce endotoxin-induced cellular energy depletion and oedema formation in the lung. Eur J Anaesthesiol 24: 258-266, 2007.
22. Konrad FM, Neudeck G, Vollmer I, Ngamsri KC, Thiel M, Reutershan J. Protective effects of pentoxifylline in pulmonary inflammation are adenosine receptor A2A dependent. FASEB J 27: 3524-3535, 2013.
23. Konrad FM, Witte E, Vollmer I, Stark S, Reutershan J. Adenosine receptor A2b on hematopoietic cells mediates LPS-induced migration of PMNs into the lung interstitium. Am J Physiol Lung Cell Mol Physiol 303: L425-L438, 2012.
24. LaPar DJ, Laubach VE, Emaminia A, Crosby IK, Hajzus VA, Sharma AK, Sumner HM, Webb DV, Lau CL, Kron IL. Pretreatment strategy with adenosine A2A receptor agonist attenuates reperfusion injury in a preclinical porcine lung transplantation model. J Thorac Cardiovasc Surg 142: 887-894, 2011.
25. Li J, Li G, Hu JL, Fu XH, Zeng YJ, Zhou YG, Xiong G, Yang N, Dai SS, He FT. Chronic or high dose acute caffeine treatment protects mice against oleic acid-induced acute lung injury via an adenosine A2A receptor-independent mechanism. Eur J Pharmacol 654: 295-303, 2011.
26. Liou GI, Auchampach JA, Hillard CJ, Zhu G, Yousufzai B, Mian S, Khan S, Khalifa Y. Mediation of cannabidiol anti-inflammation in the retina by equilibrative nucleoside transporter and A2A adenosine receptor. Invest Ophthalmol Vis Sci 49: 5526-5531, 2008.
27. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method. Methods 25: 402-408, 2001.
28. Lu Q, Harrington EO, Newton J, Casserly B, Radin G, Warburton R, Zhou Y, Blackburn MR, Rounds S. Adenosine protected against pulmonary edema through transporter-and receptor A2-mediated endothelial barrier enhancement. Am J Physiol Lung Cell Mol Physiol 298: L755-L767, 2010.
29. Luce JM. Acute lung injury and the acute respiratory distress syndrome. Crit Care Med 26: 369-376, 1998.
30. Majetschak M. Regulation of the proteasome by ATP: implications for ischemic myocardial injury and donor heart preservation. Am J Physiol Heart Circ Physiol 305: H267-H278, 2013.
31. Martin L, Pingle SC, Hallam DM, Rybak LP, Ramkumar V. Activation of the adenosine A3 receptor in RAW 264.7 cells inhibits lipopolysaccharide-stimulated tumor necrosis factor-alpha release by reducing calcium-dependent activation of nuclear factor-kappaB and extracellular signal-regulated kinase 1/2. J Pharmacol Exp Ther 316: 71-78, 2006.
32. Matute-Bello G, Downey G, Moore BB, Groshong SD, Matthay MA, Slutsky AS, Kuebler WM, Acute Lung Injury in Animals Study Group. An official American Thoracic Society workshop report: features and measurements of experimental acute lung injury in animals. Am J Respir Cell Mol Biol 44: 725-738, 2011.
33. Matute-Bello G, Frevert CW, Martin TR. Animal models of acute lung injury. Am J Physiol Lung Cell Mol Physiol 295: L379-L399, 2008.
34. Moitra J, Sammani S, Garcia JGN. Re-evaluation of Evans Blue dye as a marker of albumin clearance in murine models of acute lung injury. Transl Res 150: 253-265, 2007.
35. Murphree LJ, Sullivan GW, Marshall MA, Linden J. Lipopolysaccharide rapidly modifies adenosine receptor transcripts in murine and human macrophages: role of NF-kappaB in A(2A) adenosine receptor induction. Biochem J 391: 575-580, 2005.
36. Ngamsri KC, Wagner R, Vollmer I, Stark S, Reutershan J. Adenosine receptor A1 regulates polymorphonuclear cell trafficking and microvascular permeability in lipopolysaccharide-induced lung injury. J Immunol 185: 4374-4384, 2010.
37. Nguyen DK, Montesinos MC, Williams AJ, Kelly M, Cronstein BN. Th1 cytokines regulate adenosine receptors and their downstream signaling elements in human microvascular endothelial cells. J Immunol 171: 3991-3998, 2003.
38. Poirier C, Berdyshev EV, Dimitropoulou C, Bogatcheva NV, Biddinger PW, Verin AD. Neutral sphingomyelinase 2 deficiency is associated with lung anomalies similar to emphysema. Mamm Genome 23: 758-763, 2012.
39. Ramakers BP, Wever KE, Kox M, van den Broek PH, Mbuyi F, Rongen G, Masereeuw R, van der Hoeven JG, Smits P, Riksen NP, Pickkers P. How systemic inflammation modulates adenosine metabolism and adenosine receptor expression in humans in vivo. Crit Care Med 40: 2609-2616, 2012.
40. Reutershan J, Cagnina RE, Chang D, Linden J, Ley K. Therapeutic anti-inflammatory effects of myeloid cell adenosine receptor A2a stimulation in lipopolysaccharide-induced lung injury. J Immunol 179: 1254-1263, 2007.
41. Reutershan J, Vollmer I, Stark S, Wagner R, Ngamsri KC, Eltzschig HK. Adenosine and inflammation: CD39 and CD73 are critical mediators in LPS-induced PMN trafficking into the lungs. FASEB J 23: 473-482, 2009.
42. Rivo J, Zeira E, Galun E, Matot I. Activation of A3 adenosine receptor provides lung protection against ischemia-reperfusion injury associated with reduction in apoptosis. Am J Transplant 4: 1941-1948, 2004.
43. Ross SD, Tribble CG, Linden J, Gangemi JJ, Lanpher BC, Wang AY, Kron IL. Selective adenosine-A2A activation reduces lung reperfusion injury following transplantation. J Heart Lung Transplant 18: 994-1002, 1999.
44. Säve S, Mohlin C, Vumma R, Persson K. Activation of adenosine A2A receptors inhibits neutrophil transuroepithelial migration. Infect Immun 79: 3431-3437, 2011.
45. Schingnitz U, Hartmann K, MacManus CF, Eckle T, Zug S, Colgan SP, Eltzschig HK. Signaling through the A2B adenosine receptor dampens endotoxin-induced acute lung injury. J Immunol 184: 5271-5279, 2010.
46. Spicuzza L, Di Maria G, Polosa R. Adenosine in the airways: implications and applications. Eur J Pharmacol 533: 77-88, 2006.
47. Umapathy NS, Fan Z, Zemskov EA, Alieva IB, Black SM, Verin AD. Molecular mechanisms involved in adenosine-induced endothelial cell barrier enhancement. Vascul Pharmacol 52: 199-206, 2010.
48. Umapathy NS, Gonzales J, Fulzele S, Kim K, Lucas R, Verin AD. β-Nicotinamide adenine dinucleotide attenuates lipopolysaccharide-induced inflammatory effects in a murine model of acute lung injury. Exp Lung Res 38: 223-232, 2012.
49. Umapathy SN, Kaczmarek E, Fatteh N, Burns N, Lucas R, Stenmark KR, Verin AD, Gerasimovskaya EV. Adenosine A1 receptors promote vasa vasorum endothelial cell barrier integrity via Gi and Akt-dependent actin cytoskeleton remodeling. PloS One 8: e59733, 2013.
50. Versluis M, van den Berge M, Timens W, Luijk B, Rutgers B, Lammers JWJ, Postma DS, Hylkema MN. Allergen inhalation decreases adenosine receptor expression in sputum and blood of asthma patients. Allergy 63: 1186-1194, 2008.
51. Wagner R, Ngamsri KC, Stark S, Vollmer I, Reutershan J. Adenosine receptor A3 is a critical mediator in LPS-induced pulmonary inflammation. Am J Physiol Lung Cell Mol Physiol 299: L502-L512, 2010.
52. Ware LB, Matthay MA. The acute respiratory distress syndrome. N Engl J Med 342: 1334-1349, 2000.
53. Watorek W. Azurocidin-inactive serine proteinase homolog acting as a multifunctional inflammatory mediator. Acta Biochim Pol 50: 743-752, 2003.
54. Zhou Y, Schneider DJ, Blackburn MR. Adenosine signaling and the regulation of chronic lung disease. Pharmacol Ther 123: 105-116, 2009.